Neurontin (Gabapentin)

Gabapentin, the active ingredient in Neurontin, is an anticonvulsant presented as an oral formulation for oral use. It is employed in the management of certain seizure types and neuropathic pain conditions in adults. GNH USA supplies Neurontin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neurontin (gabapentin) is used across several neurological and pain‑related pathways. - Partial seizures: reduces the frequency and severity of focal seizures. - Postherpetic neuralgia: alleviates chronic pain following shingles. - Diabetic peripheral neuropathic pain: improves pain control in diabetic nerve damage. - Restless legs syndrome: diminishes uncomfortable sensations and urges to move the legs.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Dizziness: a sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness or fatigue. - Peripheral edema: swelling of the lower extremities.

Serious or Rare Side Effects: - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Suicidal thoughts or behavior: new or worsening depression or suicidal ideation. - Respiratory depression: especially when combined with other central depressants.

Before initiating therapy, clinicians should consider several safety measures. - Renal function assessment: dose may need adjustment in impaired kidney function. - Mood monitoring: watch for depression, anxiety, or suicidal ideation. - Discontinuation strategy: avoid abrupt cessation to reduce withdrawal risk. - Elderly caution: increased sensitivity to dizziness and sedation. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Gabapentin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: may reduce gabapentin absorption. - Opioids (e.g., morphine, oxycodone): can potentiate central nervous system depression.

Moderate Interactions (Monitor Closely): - Other CNS depressants (e.g., benzodiazepines, antihistamines): may increase sedation. - NSAIDs: may heighten the risk of peripheral edema. - Insulin or oral hypoglycemics: gabapentin can potentiate hypoglycemic effects.